Medicines New Zealand - Latest News [Page 1]

NZ research set to impact international opioid crisis

Thursday, 15 November 2018, 11:48 am | Medicines New Zealand

Ground breaking research that looks at a novel technique for pain management is set to influence the global opioid addiction crisis. More >>

Outdated public funding model failing NZ patients

Tuesday, 9 October 2018, 12:20 pm | Medicines New Zealand

Publicly funded modern medicines are out of reach for many patients in New Zealand according to a new report. The COMPARE 4 report shows New Zealand ranking the lowest out of 20 OECD countries for its market access to modern medicines. More >>

Applications closing soon for the Value of Medicines Award

Thursday, 20 September 2018, 3:26 pm | Medicines New Zealand

Only 1 week until applications close for the Value of Medicines Award 2018. The national award recognises translational, fundamental, or clinical research into existing emerging medicines or vaccines. It is open to researchers, professors, clinicians, students ... More >>

Rewarding research that continues the evolution of medicine

Thursday, 23 August 2018, 1:50 pm | Medicines New Zealand

Rewarding research that continues the evolution of medicine 23 August 2018 Applications are now open for the Medicines New Zealand 2018 Value of Medicines Award. This award highlights fundamental, translational and clinical research into both existing and ... More >>

New Zealand "isn’t treating its cancer patients fairly "

Friday, 3 August 2018, 10:25 am | Medicines New Zealand

One of Australia’s top oncologists, Professor John Zalcberg, will be in New Zealand next week highlighting New Zealand’s appalling cancer rates and its substandard outcomes for particular cancer patients. More >>

Medicines Waiting List: International disgrace

Thursday, 12 July 2018, 3:26 pm | Medicines New Zealand

The medicines waiting list grows to over 100 priority medicines that wait to be publicly funded by PHARMAC. All medicines on this list have been recommended to benefit patients and New Zealand’s healthcare system by PHARMAC’s own technical advisory board. More >>

Rationing medicines by stealth with budget announcement

Thursday, 17 May 2018, 5:30 pm | Medicines New Zealand

Big expectations from the Government today as it increases the pressure on PHARMAC to perform with its savings model. More >>

230,000 patients have inequitable access to modern medicines

Thursday, 19 April 2018, 11:37 am | Medicines New Zealand

More than 230,000 New Zealand patients are deprived from accessing a range of modern medicines shown by the latest information published in New Zealand’s Medicines Landscape. More >>

NZ research influences international treatment for gout

Thursday, 15 February 2018, 9:50 am | Medicines New Zealand

Otago University’s Professor Lisa Stamp will receive the Medicines New Zealand 2017 Value of Medicines Award tonight for her breakthrough research into gout. Her research was the first randomized controlled trial to demonstrate an improved dosing ... More >>

Equitable access to breakthrough medicines needed

Thursday, 1 February 2018, 3:14 pm | Medicines New Zealand

Former clinical leader, Dr. Lee Mathias, has been appointed as new chair for Medicines New Zealand the industry association for the biopharmaceutical presence in New Zealand. More >>

Medicines New Zealand seeks independent chair for 2018

Monday, 13 November 2017, 3:49 pm | Medicines New Zealand

Medicines New Zealand independent Chair, Hon. Heather Roy has announced she is leaving the role after representing the Pharmaceutical industry for six years. More >>

Researchers succeed after the Value of Medicines Award

Monday, 21 August 2017, 3:30 pm | Medicines New Zealand

The Value of Medicines Award recognises research that improves the understanding, effectiveness or safety of the use of medicines in New Zealand and applications for the $20,000 award are open until 6th October 2017. More >>

Recognising Research Excellence: Value Of Medicines Award

Monday, 31 July 2017, 3:28 pm | Medicines New Zealand

Applications are now open for the Medicines New Zealand 2017 Value of Medicines Award. The award recognises research that improves the understanding, effectiveness or safety of the use of medicines in New Zealand. More >>

Founder of HPV Vaccine guest of honour at Parliament

Wednesday, 21 June 2017, 3:23 pm | Medicines New Zealand

Founder of HPV Vaccine guest of honour at Parliamentary Dinner. Professor Ian Frazer founder of the HPV vaccine is the guest speaker at the Medicines New Zealand Parliamentary dinner this evening, hosted at Parliament by the Chair of Health Committee, Simon ... More >>

Red carpet for inventor of world’s first cancer vaccine

Monday, 19 June 2017, 4:18 pm | Medicines New Zealand

NZ rolls out red carpet for inventor of world’s first cancer vaccine. Pioneering Australian researcher and 2006 Australian of the Year, Professor Ian Frazer, is paying a short visit to New Zealand this week. He is a guest of honour at the Medicines ... More >>

Patient Voice Prompts New Medicines Funding

Sunday, 7 May 2017, 8:33 pm | Medicines New Zealand

Medicines New Zealand is pleased that the New Zealand Government has today announced an additional investment of $60 million towards new medicines. More >>

Medicines in New Zealand are overlooked and underfunded

Friday, 5 May 2017, 9:15 am | Medicines New Zealand

Medicines New Zealand today released their latest Annual Report, The New Zealand Medicines Landscape 2016. It reveals patients in New Zealand are at the end of the queue for cost-effective, innovative medicines compared with other countries. More >>

Paracetamol wins Wellington researchers $20,000 prize

Monday, 10 October 2016, 9:48 am | Medicines New Zealand

Dr Paul Young will be presented with Medicines New Zealand’s 2016 Value of Medicines Award for leading a world-class study into the effects paracetamol has on patients in intensive care units (ICU) this evening. More >>

Research shows new cancer medicines pay for themselves

Tuesday, 23 August 2016, 4:06 pm | Medicines New Zealand

Research by prominent American economist, Professor Frank Lichtenberg, proves New Zealand’s investment in cancer medicines reduces hospital spending, contributes to improved survival rates and decreases premature mortality rates. More >>

Economist visits NZ to present cancer research

Monday, 22 August 2016, 10:54 am | Medicines New Zealand

Renowned American economist, Professor Frank Lichtenberg, has been commissioned by Medicines New Zealand to analyse the impact new cancer medicines have on New Zealand patients and the healthcare system. More >>

 

 

InfoPages Links

 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL